Risk stratified randomized controlled trial in paediatric Crohn´s Disease: Methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or at high risk for aggressive disease course, respectively - a treatment strategy Risk stratified randomized controlled trial in paediatric Crohn´s Disease: Methotrexate versus azath ...
Risk stratified randomized controlled trial in paediatric Crohn´s Disease: Methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or at high risk for aggressive disease course, respectively - a treatment strategy - REDUCE-RISK in CD-PIBD-TRIAL Risk stratified randomized controlled trial in paediatric Crohn´s Disease: Methotrexate versus azath ...
Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]